RIZZI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 1.634
EU - Europa 1.064
AS - Asia 638
AF - Africa 125
OC - Oceania 2
SA - Sud America 2
Totale 3.465
Nazione #
US - Stati Uniti d'America 1.628
GB - Regno Unito 344
CN - Cina 264
SE - Svezia 157
SG - Singapore 143
DE - Germania 141
IT - Italia 140
VN - Vietnam 133
IE - Irlanda 66
IN - India 66
TG - Togo 65
RU - Federazione Russa 55
FR - Francia 43
EE - Estonia 30
ZA - Sudafrica 30
BG - Bulgaria 22
JO - Giordania 19
UA - Ucraina 18
FI - Finlandia 15
NG - Nigeria 15
CI - Costa d'Avorio 14
BE - Belgio 12
IR - Iran 10
NL - Olanda 8
CH - Svizzera 7
CA - Canada 4
AU - Australia 2
MX - Messico 2
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
RO - Romania 1
TR - Turchia 1
Totale 3.465
Città #
Southend 326
Chandler 223
Fairfield 168
Singapore 130
Ashburn 115
Wilmington 95
Santa Clara 94
Houston 89
Seattle 86
Dong Ket 73
Ann Arbor 69
Dublin 66
Princeton 66
Lomé 65
Woodbridge 63
Cambridge 53
Boardman 39
Bologna 39
Nanjing 36
Padova 32
Westminster 31
Jinan 30
Berlin 25
Bremen 22
Sofia 22
Shenyang 20
Turin 20
Amman 19
Tianjin 18
Dearborn 16
Hebei 16
Medford 16
Abeokuta 15
Helsinki 15
Abidjan 14
Falls Church 14
New York 14
Saint Petersburg 14
Mountain View 12
San Diego 12
Brussels 11
Florence 11
Changsha 10
Hangzhou 9
Nanchang 9
Kuban 8
Los Angeles 8
Guangzhou 7
Haikou 7
Zhengzhou 7
Beijing 6
Fuzhou 5
Ningbo 5
Norwalk 5
Olalla 5
Redwood City 5
Andover 4
Bühl 4
Jiaxing 4
Kunming 4
Leawood 4
Modena 4
Monmouth Junction 4
Taiyuan 4
Wuhan 4
York 4
Assisi 3
Groningen 3
Henderson 3
Lausanne 3
Milan 3
Naples 3
Paris 3
Shanghai 3
Taizhou 3
Toronto 3
Zanjan 3
Castenaso 2
Città di Castello 2
Costa Mesa 2
Den Haag 2
Foshan 2
Frattamaggiore 2
Harbin 2
Hefei 2
Hyderabad 2
London 2
Muizenberg 2
Phoenix 2
Pune 2
Redmond 2
Shenzhen 2
Spello 2
Ulan-ude 2
Walnut 2
Yantai 2
Ardabil 1
Athens 1
Baoding 1
Basra 1
Totale 2.525
Nome #
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 207
10 YEARS ONCOLOGIC OUTCOMES OF Robot-assISTED RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCH ANALYSIS COMPARED WITH OPEN APPROACH 143
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 141
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 135
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 132
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. 123
Impact of environmental enrichment on neurogenesis in the dentate gyrus during the early postnatal period. 122
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 120
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 116
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 116
[Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients]. 111
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 111
Warm ischemia time and postoperative complications after partial nephrectomy for renal cell carcinoma. 110
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 110
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 109
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 108
TRIFECTA RATES IN A COHORT OF PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS AT LOW-INTERMEDIATE COMPLEXITY: A SINGLE-INSTITUTIONAL ANALYSIS 106
Revised Gleason Grading System Is a Better Predictor of Indolent Prostate Cancer at the Time of Diagnosis: Retrospective Clinical-Pathological Study on Matched Biopsy and Radical Prostatectomy Specimens. 105
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 104
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 99
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 98
PERIOPERATIVE RESULTS , EARLY ONCOLOGICAL OUTCOMES AND TRIFECTA RATE IN PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS: A SINGLE INSTITUTIONAL ANALYSIS 94
THE PROGNOSTIC IMPACT OF TUMOR SIZE ON CANCER-SPECIFIC AND OVERALL SURVIVAL AMONG PATIENTS WITH PATHOLOGIC T3A RENAL CELL CARCINOMA 93
VALIDATION OF PRIAS ACTIVE SURVEILLANCE CRITERIA IN PATIENTS SUBMITED TO RADICAL PROSTATECTOMY 90
Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score. 89
Neonatal isolation impairs neurogenesis in the dentate gyrus of the guinea pig. 88
In patients with pathologically positive lymph nodes, three positive nodes represent a significant and independent cut-point for cancer-specific and overall survival 82
PREOPERATIVE 11C-CHOLINE PET-CT IN INTERMEDIATE, HIGH RISK AND VERY HIGH RISK PROSTATE CANCER PATIENTS: IS THERE STILL ANY ROOM LEFT FOR IT? 79
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 78
RUOLO DELLA LYMPH-NODE DENSITY NELL’OUTCOME ONCOLOGICO DEI PAZIENTI CON METASTASI LINFONODALI DA CARCINOMA prostatico SOTTOPOSTI A PROSTATECTOMIA RADICALE E LINFADENECTOMIA PELVICA 77
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 61
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas 61
null 51
Validation of PRIAS Active Surveillance criteria in patients submitted to radical prostatectomy 49
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 28
Totale 3.546
Categoria #
all - tutte 8.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.907


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020562 0 0 0 0 0 74 94 112 136 45 25 76
2020/2021312 72 32 3 2 8 3 9 8 51 9 4 111
2021/2022644 101 30 29 34 58 32 14 37 22 35 147 105
2022/2023855 76 175 50 112 57 59 24 55 154 18 61 14
2023/2024221 23 37 6 29 24 45 7 21 2 19 2 6
2024/2025387 32 86 54 71 126 18 0 0 0 0 0 0
Totale 3.546